RxSight (RXST) Non-Current Debt (2020 - 2023)

RxSight's Non-Current Debt history runs 4 years deep, the most recent figure standing at $19.6 million for Q2 2023.

• Quarterly Non-Current Debt fell 50.88% year-over-year to $19.6 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $19.6 million (down 50.88% YoY) and the FY2022 annual result came in at $40.2 million, up 1.03% from the prior year.
• Non-Current Debt was $19.6 million for Q2 2023 at RxSight, down from $40.3 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $40.3 million in Q1 2023 and bottomed at $19.6 million in Q2 2023.
• A 4-year average of $36.3 million and a median of $39.8 million in 2021 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2021 — Non-Current Debt soared 62.96% — and 2023, when it slumped 50.88%.
• RxSight's Non-Current Debt stood at $24.4 million in 2020, then surged by 62.96% to $39.8 million in 2021, then advanced by 1.03% to $40.2 million in 2022, then plunged by 51.23% to $19.6 million in 2023.
• Business Quant data shows RXST's Non-Current Debt at $19.6 million in Q2 2023, $40.3 million in Q1 2023, and $40.2 million in Q4 2022.